GREEN CROSS LAB CELL
GC Green Cross Their goal is to contribute to the healthy life of mankind and become a global leader in the healthcare industry. Recent advances in biotechnology have become a good foundation for achieving their goals. The paradigm of medicine is changing. They are shifting from traditional medicines and synthetic medicines to biopharmaceutical development. GC Green Cross Cellular gene therapy, which is the main pipeline of LAPSEL, is expected to enable the treatment of rare and intractable dis... eases as well as cancer, because of the fundamental treatment of diseases at the gene and cell level. In particular, successful cases such as approval of the first immunotherapeutic drug (CAR-T) in 2017 and the approval of the first gene therapy (Luxturna) were epoch-making events that transformed the expectations they had in mind into reality. Is added.
GREEN CROSS LAB CELL
Industry:
Biotechnology
Status:
Active
Contact:
82 3 1260 9600
Technology used in webpage:
Apache Korea Telecom
Similar Organizations
Lutris Pharma
Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness.
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-07-16 | GC Cell | GC Cell acquired by Green Cross Lab Cell | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-02-26 | Artiva Biotherapeutics | Green Cross Lab Cell investment in Series B - Artiva Biotherapeutics | 120 M USD |
| 2020-06-26 | Artiva Biotherapeutics | Green Cross Lab Cell investment in Series A - Artiva Biotherapeutics | 78 M USD |